Skip to content

The Investigation of the Impact of Early Mobilization on the Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.

The Investigation of the Impact of Early Mobilization on the Outcome, the Appearance of Early Ischemic Damage, the Functional Status, and the Length of Intensive Care Treatment in Patients With Aneurysmal Subarachnoid Hemorrhage.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06436508
Enrollment
50
Registered
2024-05-31
Start date
2023-06-14
Completion date
2026-03-31
Last updated
2024-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Ambulation, Standard of Care, Subarachnoid Hemorrhage, Aneurysmal

Keywords

subarachnoid hemorrhage, early mobilization

Brief summary

The goal of the randomized clinical trial is to examine the effect of early mobilization on primary and secondary outcomes in patients with subarachnoid hemorrhage caused by aneurysm rupture. Researchers will compare early mobiliziation vs. standrad bed rest care.

Interventions

* Step 1 - Day 1: Bed rest, elevation of the head end to 30° * Step 2 - Day 2: Bed rest, elevation of the head end to 60° * Step 3 - Day 3: Bed rest, elevation of the head end to 80° * Step 4 - Day 4: Sitting on the edge of the bed * Step 5 - Day 5: Sitting in a chair, standing up * Step 6 - Day 6: Walking with or without assistance * Step 7 - Day 7: Walking with or without assistance from today

BEHAVIORALStandard care

During standard care, early mobilization does not take place in the intensive care unit; the patient receives only standard supportive care in bed rest.

Sponsors

National Institute of Mental, Neurological and Neurosurgery
CollaboratorUNKNOWN
Borsod-Abaúj-Zemplén County Central Hospital and University Teaching Hospital
CollaboratorUNKNOWN
University of Pecs
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age \>18 ys * Premorbid modified Rankin Scale score of 0-2 * WFNS I-IV at enrollment * Aneurysm occlusion has occurred through open or endovascular means * Minimum 24 hours elapsed after aneurysm occlusion * The patient has not received thrombolytic therapy * Vital parameters are appropriate (mean arterial pressure \[MAP\] \>80 or \>110 mm Hg) * Signed patient information and consent form * Enrollment occurs within 72 hours following ictus

Exclusion criteria

* Age under 18 years * Traumatic subarachnoid hemorrhage * Incapacitated or limited capacity for action before ictus * Confirmed pregnancy * Aneurysm multiplicity (unless all aneurysms are treated)

Design outcomes

Primary

MeasureTime frameDescription
Disability in early mobilization group (EM) vs. standard care group (SC) - modified Rankin score14 day; 3 monthsOutcome assessments will include: Modified Rankin Scale Disability is assessed by the modified Rankin Scale, dichotomized at a score of 0 to 3 versus 4 to 6 (6=death).Assessment is performed by a blinded investigator of the local study center by personal visit.
Disability in early mobilization group (EM) vs. standard care group (SC) - Extended Glasgow Outcome Scale14 day; 3 monthsExtended Glasgow Outcome Scale Description of the neurological outcome by using extended Glasgow Outcome Score 1. Death 2. Vegetative sate 3. Lower severe disability 4. Upper severe disability 5. Lower moderate disability 6. Upper moderate disability 7. Lower good recovery 8. Upper good recovery Assessment is performed by a blinded investigator of the local study center by personal visit.

Secondary

MeasureTime frameDescription
Stay in the Intensive Care Unit (ICU)Up to 28 daysLength of stay in the Intensive Care Unit (ICU)
Type of post-hospital discharge placementUp to 30 dayshome discharge, rehabilitation, chronic care, etc.
Readmission to the ICUUp to 30 daysrepeated ICU treatment following ward discharge
Occurrence of infection and its time in the intensive care unitUp to 30 daysinfection and its time in the intensive care unit
Onset of delayed cerebral ischemia (DCI)3-21 daysOccurence of DCI after aneurysmal subarachnoid hemorrhage
Functional Independence Measure (FIM) scale14 dayThe FIM's assessment of degree of disability depends on the patient's score in 18 categories, focusing on motor and cognitive function. Each category or item is rated on a 7-point scale (1 = \<25% independence; total assistance required, 7 = 100% independence) Assessment is performed by a blinded investigator of the local study center by personal visit.
Montreal Cognitive Assessment (MoCA)14 day; 3 monthsMoCA scores range between 0 and 30. The MoCA is used for assessment for detecting cognitive impairment. A score of 26 or over is considered to be normal. Assessment is performed by a blinded investigator of the local study center by personal visit.
Hospital Anxiety and Depression Scale (HADS)14 day; 3 monthsEach item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. Items are rated on a 4-point severity scale. The HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Scores of greater than or equal to 11 on either scale indicate a definitive case. Assessment is performed by a blinded investigator of the local study center by personal visit.
Barthel score14 day; 3 monthsFor assessing activities of daily living in patients with aneurysmal subarachnoid hemorrhage; ordinal scale rates bowel function, bladder function, grooming, toilet use, feeding independence, transfer independence, mobility, dressing ability, stair use, and bathing ability to tabulate a composite score ranging from 0 to 100. Score of 100 represents totally independent. Assessment is performed by a blinded investigator of the local study center by personal visit.
Onset of severity of macrovascular vasospasmUp to 14 daysbased on cerebral vasospasm grade Grade 0 All intracranial vessels show a physiological shape Grade 1 Vasospasm affects the A2, A1, and M2 segments Grade 2 Vasospasm expands to the M1 and terminal segment of the internal carotid artery Grade 3 Severe reduction in the intradural internal carotid artery with filiform A1 and M1 segments, which sometimes appears like a ghost (ghost sign)

Countries

Hungary

Contacts

Primary ContactPeter Csecsei, MD. PhD
csecsei.peter@pte.hu+0672535900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026